His hope is that additional research would provide more definitive conclusions to help physicians choose the best medications for
patients after a heart attack and, ultimately, «to reduce the too - high rate of death and disability for
patients after a heart attack,» Bach said.
Complementing the work of my colleagues in the Roddenberry Center for Stem Cell Biology and Medicine at Gladstone, our efforts to learn more about how the heart forms can improve methods for creating heart cells from stem cells, either in a petri dish or inside
a patient after a heart attack.
Not exact matches
Patients can use the app to keep track of medication regimens and follow - up appointments, as well as receive guidance with lifestyle changes needed
after a
heart attack.
Later, at his own practice in the Twin Cities, he began injecting stem cells into
patients»
hearts to regrow muscle
after a
heart attack.
ORLANDO, Fla. — The first large study to examine cumulative radiation exposure from medical imaging
after a
heart attack has found that the average
patient receives the equivalent of about 725 chest X-rays before leaving the hospital.
In the days
after a
heart attack, surviving
patients and their loved ones can breathe a sigh of relief that the immediate danger is over — but the scar tissue that forms during the long healing process can inflict lasting damage.
As for COX - 2, in late September, drug giant Merck pulled its COX - 2 inhibitor Vioxx off the market
after a study found that
patients on Vioxx suffered more
heart attacks.
Following additional scrutiny
after Vioxx's withdrawal, and the addition of cardiovascular experts to the trial's data safety monitoring board, the DSMB concluded that
patients taking a high dose of Celebrex had a 3.4-fold increase in the risk of
heart attacks or strokes compared to those on placebo; those on a moderate dose had a 2.5-fold increase in risk.
Charging that thousands of
patients are being misled and may be unnecessarily placed at increased risk of death, a U.S. watchdog group last week demanded that federal regulators suspend a major clinical trial exploring when to offer blood transfusions
after a
heart attack.
After a
heart attack, cells from the
patient's bone marrow can help improve
heart function.
The study used clinical measurements for maximum reliability in identifying
heart attacks, because symptoms are masked by pain - killing drugs in more than 50 percent of
patients who have
heart attacks after surgery.
On the other hand, because treatment has improved, more
patients are alive
after a
heart attack to subsequently get
heart failure.»
The clear result of this clinical study — that the combination reduced strokes,
heart attacks and cardiovascular death by practically 25 per cent compared to either drug alone in both
patients with stable coronary or peripheral artery disease — caused the clinical trial to be stopped early,
after 23 months, in February 2017.
Since then, other researchers have made headlines
after reporting the genetic fingerprints of C. pneumonia, as well as several kinds of common mouth bacteria, in the arterial plaque of
heart attack patients.
In the past few years alone, researchers have had to backtrack on the health benefits of low - fat, high - fiber diets and the value and safety of hormone replacement therapy as well as the arthritis drug Vioxx, which was pulled from the market
after being found to cause
heart attacks and strokes in high - risk
patients.
We put
patients on Heparin, a blood - thinning medication,
after a
heart attack.
After adjusting for baseline characteristics the researchers found that the rates of stroke and subsequent
heart attacks were similar between the two groups, but
patients prescribed antidepressants had significantly worse survival.
She concluded: «Our study showed that many
patients are treated with antidepressants
after a
heart attack.
In addition, when
patients are started on conservative, low doses in the hospital
after a
heart attack, they return home so quickly, there is little time to adjust the dosage, Goldberger said.
Overall, the percentage of
heart attack patients who survive the first six months
after their
attack has gone up since 1999 — from 73 percent to 78.5 percent.
The observational study of nearly 9,000
patients found that those prescribed antidepressants at discharge from hospital
after a
heart attack had a 66 % greater risk of mortality one year later than
patients not prescribed the drugs, although they noted the cause is not necessarily related directly to the antidepressants.
In this new study, they looked at cancer risk in
patients who developed
heart failure
after their first
heart attack.
OBTAIN (Outcomes of Beta - Blocker Therapy
After Myocardial Infarction) is an observational multicenter registry in which beta - blocker dosing information was collected in
patients with an acute
heart attack at participating centers to assess the effect of dose on survival.
After a
heart attack, healthcare providers routinely focus on preventing complications, such as recurrent
heart attacks,
heart failure and whether a
patient returns to work.
Despite a high number of
heart attack patients returning to their jobs shortly
after the event, the new findings reveal a surprisingly high degree of unemployment within a year
after a
heart attack patient returns to work.
Researchers chose to compare those with and without
heart failure
after heart attack because these
patient groups have a lot in common, including atherosclerosis, risk factors, treatments received and follow - up routines.
Patients who developed heart failure after heart attack were prescribed the same medications at discharge as those who were not, so researchers concluded treatment for heart attack was not likely responsible for the higher rate of cancer in heart failure p
Patients who developed
heart failure
after heart attack were prescribed the same medications at discharge as those who were not, so researchers concluded treatment for
heart attack was not likely responsible for the higher rate of cancer in
heart failure
patientspatients.
«Low dose beta - blockers as effective as high dose
after a
heart attack: Surprisingly,
heart attack patients live as long — or even longer — on one - fourth the suggested dose.»
Hospitals that focused on getting
heart attack patients diagnosed and onto the angioplasty table within the first 24 hours
after their first symptoms achieved the biggest gains in survival.
The researchers recruited 5,380
patients with type 2 diabetes
after the
patient had a major but nonfatal acute coronary syndrome such as a
heart attack, or hospitalization for unstable angina.
After 50 years of being a mainstay cholesterol therapy, niacin should no longer be prescribed for most
patients due to potential increased risk of death, dangerous side effects and no benefit in reducing
heart attacks and strokes, writes Northwestern Medicine ® preventive cardiologist Donald Lloyd - Jones, M.D., in a New England Journal of Medicine editorial.
Functional IMR affects 1.6 million to 2.8 million
patients in the U.S. and is associated with a doubling in mortality among
patients with mild or greater degrees of mitral regurgitation
after a
heart attack.
Clinicians should be aware of this and also consider that
patients who arrive in the emergency department with signs of
heart attacks, such as chest pain and breathlessness, but
after a happy event or emotion, could be suffering from TTS just as much as a similar
patient presenting
after a negative emotional event.
After an average follow - up time of 43 months, 105
patients or 17 percent in the DEFER group and 109 or 18 percent in the standard treatment group met the primary endpoint, a composite of death from any cause, hospitalization for
heart failure, a second
heart attack, and unplanned repeat angioplasty, a nonsignificant difference.
Sex is rarely the cause of a
heart attack, and most
heart disease
patients are safe to resume sexual activity
after a
heart attack, according to a research letter published today in the Journal of the American College of Cardiology.
After a
heart attack, standard practice calls for putting
patients on a lifetime regimen of daily aspirin to prevent clotting and reduce the chance of another
heart attack.
«Sex does not increase
heart attack risk, study suggests:
Patients should be encouraged to resume sexual activity
after heart attack.»
After a
heart attack or stroke,
patients are often given a drug called heparin to prevent blood clots.
For example, it may be possible to initiate tissue regeneration
after heart attacks without having a
patient undergo difficult, invasive surgery, but a great deal of additional research is required.
The clinical trial differs from the pig trial in that it is testing whether ultrasound / microbubbles alone administered to
heart attack patients both before and
after balloon angioplasty and stenting results in better
patient outcomes compared with balloon angioplasty and stenting alone.
But it has not been clear until now that the effects of these particular gene variations can vary by race in
patients taking clopidogrel
after a
heart attack.
Eight of Strober's 12 trial
patients have now been free of immunosuppressive treatment for up to three years, although one died
after three years from a
heart attack unrelated to the treatment.
In turn, the injury in the
heart muscle
after a
heart attack develops a progressive signal that triggers structural pathology and complications in the kidneys, which can affect survival in
heart attack patients.
The percutaneous
heart pump (PHP) developed at Penn State, shown here with a model of the left ventricle of a human
heart, can keep a
patient's blood flowing smoothly
after a
heart attack.
The scientists are urging doctors to provide intensive support to female
heart attack patients, above all in the first 365 days
after the event.
In any case, he says, the spotlight now shifts to the doctors of women recovering from
heart attacks: «Our study shows that it is important to pay close attention to female
patients especially in the first year
after the event.»
«Anxiety as a protective factor
after a
heart attack: Female
patients with anxiety disorder react more quickly to a
heart attack.»
The time difference between female
heart attack patients with and without anxiety disorder was particularly marked: on average, the former reached a hospital 112 minutes
after the onset of a
heart attack, while their counterparts without anxiety disorder took around two hours longer.
A study published this month using the same group of
patients found that the risk of dying in the month
after a
heart attack was 14 percent in the under -6-METs group but only 6 percent in the over-12-METs group.
Through the UCSD Clinical Cardiovascular Cell Therapy program, Dib and collaborating cardiology faculty plan to conduct clinical studies in a number of areas, including the effectiveness of adult stem cell transplant as a treatment for congestive
heart failure; as a way to minimize
heart damage
after a
heart attack; and in the formation of new blood vessels (angiogenesis) to increase blood flow to the
heart for
patients experiencing chest pain.